News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
306,085 Results
Type
Article (15255)
Company Profile (283)
Press Release (290547)
Section
Business (91457)
Career Advice (160)
Deals (16158)
Drug Delivery (35)
Drug Development (53616)
Employer Resources (31)
FDA (6838)
Job Trends (5532)
News (164913)
Policy (12308)
Tag
Academia (951)
Alliances (26031)
Alzheimer's disease (853)
Antibody-drug conjugate (ADC) (78)
Approvals (6855)
Artificial intelligence (104)
Bankruptcy (108)
Best Places to Work (4798)
Biotechnology (235)
Breast cancer (142)
Cancer (1214)
Cardiovascular disease (93)
Career advice (140)
CAR-T (99)
Cell therapy (294)
Clinical research (43391)
Collaboration (473)
Compensation (191)
COVID-19 (1112)
C-suite (127)
Data (1235)
Diabetes (113)
Diagnostics (1723)
Earnings (33705)
Events (51708)
Executive appointments (384)
FDA (7418)
Funding (441)
Gene editing (79)
Gene therapy (217)
GLP-1 (360)
Government (1193)
Healthcare (7121)
Infectious disease (1169)
Inflammatory bowel disease (111)
IPO (8086)
Job creations (1037)
Job search strategy (135)
Layoffs (201)
Legal (2132)
Lung cancer (176)
Lymphoma (77)
Manufacturing (116)
Medical device (3506)
Medtech (3508)
Mergers & acquisitions (8351)
Metabolic disorders (340)
Neuroscience (1184)
NextGen: Class of 2025 (2134)
Non-profit (891)
Northern California (1423)
Obesity (175)
Opinion (98)
Parkinson's disease (92)
Patents (98)
People (27938)
Phase I (14981)
Phase II (19998)
Phase III (13062)
Pipeline (581)
Postmarket research (991)
Preclinical (6236)
Radiopharmaceuticals (218)
Rare diseases (261)
Real estate (1865)
Regulatory (9968)
Research institute (978)
Series A (85)
Southern California (1268)
Startups (2174)
United States (11349)
Vaccines (206)
Weight loss (97)
Date
Today (81)
Last 7 days (485)
Last 30 days (1663)
Last 365 days (21620)
2025 (3350)
2024 (21855)
2023 (23966)
2022 (30247)
2021 (31138)
2020 (26588)
2019 (18342)
2018 (13444)
2017 (15638)
2016 (13740)
2015 (16812)
2014 (12452)
2013 (9312)
2012 (9526)
2011 (9706)
2010 (9313)
Location
Africa (195)
Asia (29924)
Australia (4348)
California (3251)
Canada (1057)
China (323)
Colorado (121)
Connecticut (134)
Europe (44231)
Florida (373)
Georgia (95)
Illinois (202)
Indiana (78)
Japan (101)
Maryland (438)
Massachusetts (2600)
Minnesota (146)
New Jersey (855)
New York (907)
North Carolina (501)
Northern California (1423)
Ohio (99)
Pennsylvania (607)
South America (272)
Southern California (1268)
Texas (355)
Washington State (299)
306,085 Results for "immunocellular therapeutics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
EOM PHARMACEUTICAL HOLDINGS, INC. ANNOUNCES NAME CHANGE FROM IMMUNOCELLULAR THERAPEUTICS, LTD.
EOM Pharmaceutical Holdings, Inc. (“EOM”), a clinical-stage pharmaceutical company, today announced its name change from ImmunoCellular Therapeutics Ltd., to EOM Pharmaceutical Holdings, Inc.
November 10, 2022
·
3 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Press Releases
Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering
February 27, 2025
·
2 min read
Press Releases
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best- and First-in-Class Ophthalmic Medicines
December 12, 2024
·
4 min read
Press Releases
Kestra Medical Technologies, Ltd. Appoints Neil Bhalodkar as Vice President of Investor Relations
February 26, 2025
·
1 min read
Press Releases
SEED Therapeutics Appoints Eisai Co., Ltd.’s Dr. Yoshiharu Mizui to Board of Directors
September 12, 2024
·
2 min read
Press Releases
Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering
February 26, 2025
·
5 min read
Business
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. announced the companies have completed an exclusive worldwide license agreement for the rights to MZE001, an investigational oral glycogen synthase 1 inhibitor that aims to address Pompe disease by limiting disease-causing glycogen buildup.
May 10, 2024
·
6 min read
Press Releases
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
February 21, 2025
·
4 min read
1 of 30,609
Next
